GSK to market Faes Farma's Bilastine in Spain and Poland
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has signed an agreement with Italy's Menarini to market Faes Farma's antihistamine Bilastine in Spain and Poland. Menarini holds a promotion and distribution license for the product in 51 countries including the EU's member states and ex-Soviet republics, since 2007.